Susac Syndrome: Description of a Single-Centre Case Series.
Susac syndrome
branch retinal artery occlusion
central nervous system disorder
sensorineural hearing loss
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
04 Nov 2022
04 Nov 2022
Historique:
received:
09
09
2022
revised:
24
10
2022
accepted:
02
11
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
12
11
2022
Statut:
epublish
Résumé
This study describes the clinical characteristics, diagnostic results, treatment regimens, and clinical course of a cohort of patients with Susac syndrome (SS). It is a retrospective observational study of all patients with the diagnosis of SS evaluated at the Hospital Clinic (Barcelona, Spain) between March 2006 and November 2020. Nine patients were diagnosed with SS. The median time from the onset of the symptoms to diagnosis was five months (IQR 9.0), and the median follow-up time was 44 months (IQR 63.5). There was no clear predominance of sex, and mean age of symptoms onset was 36 years (range 19-59). Six patients (67%) presented with incomplete classical clinical triad, but this eventually developed in six patients during the disease course. Encephalopathy, focal neurological signs, visual disturbances, and hearing loss were the most frequent manifestations. Brain magnetic resonance imaging showed callosal lesions in all patients. Most were in remission within two years. Only four patients met the proposed criteria for definite SS. When SS is suspected, a detailed diagnostic workup should be performed and repeated over time to identify the clinical manifestations that will lead to a definite diagnosis.
Identifiants
pubmed: 36362776
pii: jcm11216549
doi: 10.3390/jcm11216549
pmc: PMC9656090
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Intern Med. 2020 Aug 18;173(4):315-317
pubmed: 32628529
Autoimmun Rev. 2014 Aug;13(8):814-21
pubmed: 24727151
Autoimmun Rev. 2014 Apr-May;13(4-5):347-50
pubmed: 24424186
Ann Rheum Dis. 2006 Dec;65(12):1545-50
pubmed: 16569688
Int J Stroke. 2020 Jul;15(5):484-494
pubmed: 29319463
J Neuroinflammation. 2014 Mar 08;11:46
pubmed: 24606999
J Neuroophthalmol. 2019 Mar;39(1):60-67
pubmed: 29933288
J Neuroophthalmol. 2017 Jun;37(2):149-153
pubmed: 27984352
J Neurol Neurosurg Psychiatry. 2015 May;86(5):582-4
pubmed: 25168394
J Neurol Sci. 2015 Oct 15;357(1-2):50-7
pubmed: 26148931
Eur J Neurol. 2012 Jun;19(6):800-11
pubmed: 22221557
Nat Commun. 2019 Dec 18;10(1):5779
pubmed: 31852955
Nat Rev Neurol. 2013 Jun;9(6):307-16
pubmed: 23628737
Eur J Neurol. 2022 Jun;29(6):1771-1781
pubmed: 35262238
BMC Neurol. 2020 Sep 2;20(1):332
pubmed: 32878610
J Neurol Sci. 2007 Jun 15;257(1-2):215-20
pubmed: 17324441
Mult Scler Relat Disord. 2019 Aug;33:94-99
pubmed: 31176296
J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1287-1295
pubmed: 28103199
J Med Toxicol. 2015 Mar;11(1):124-8
pubmed: 25142038
Brain. 2022 Apr 29;145(3):858-871
pubmed: 35136969
Case Rep Neurol. 2020 Feb 21;12(1):78-83
pubmed: 32231548
Stroke. 1988 May;19(5):604-7
pubmed: 3363593
Medicine (Baltimore). 2016 Oct;95(43):e5223
pubmed: 27787385
Curr Treat Options Neurol. 2016 Jan;18(1):3
pubmed: 26715396
Curr Treat Options Neurol. 2008 Jan;10(1):67-74
pubmed: 18325301